Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.906
+0.046 (2.47%)
At close: Sep 5, 2025, 4:00 PM
1.940
+0.034 (1.78%)
Pre-market: Sep 8, 2025, 8:21 AM EDT

APUS Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-3.71-1.39-0.78-0.67-1.03
Stock-Based Compensation
1.89-0.070.190.19
Other Operating Activities
0.120.120.040.030.01
Change in Accounts Payable
-0.180.540.05-00
Change in Other Net Operating Assets
-1.790-0.010-0
Operating Cash Flow
-3.67-0.73-0.63-0.45-0.82
Short-Term Debt Issued
-0.330.010.28-
Long-Term Debt Issued
----0.4
Total Debt Issued
0.490.330.010.280.4
Short-Term Debt Repaid
---0.03--
Total Debt Repaid
-0.09--0.03--
Net Debt Issued (Repaid)
0.40.33-0.020.280.4
Issuance of Common Stock
11.95-1.06--
Financing Cash Flow
12.350.331.030.280.4
Net Cash Flow
8.67-0.410.4-0.17-0.42
Levered Free Cash Flow
-2.14-0.29-0.35-0.2-
Unlevered Free Cash Flow
-2.06-0.22-0.32-0.18-
Change in Working Capital
-1.970.540.04-00
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q